If you've been diagnosed with type 2 diabetes or prediabetes, you've likely heard about two common treatment options: metformin and GLP-1 receptor agonists, such as semaglutide and tirzepatide.
Both medications can improve blood sugar, but they work in very different ways. Many people wonder whether one is "better" than the other. The answer depends on your medical history, treatment goals, other health conditions, and personal preferences. In many cases, these medications are not competitors—they're complementary treatments that may even be used together.
Note: tirzepatide is technically a dual GIP/GLP-1 receptor agonist rather than a GLP-1 receptor agonist alone. Because it is commonly discussed alongside GLP-1 medications, this article refers to them together while recognizing the difference in how they work.
What Is Metformin?
Metformin has been the first-line medication for type 2 diabetes for decades. It primarily works by reducing glucose production by the liver, improving insulin sensitivity, and helping your body use insulin more effectively.
Metformin does not stimulate the pancreas to release more insulin, which is one reason it has a very low risk of causing hypoglycemia when used by itself. It is available as a generic medication and has one of the longest safety records of any diabetes medication.
What Are GLP-1 Medications?
GLP-1 medications mimic or enhance hormones involved in blood sugar regulation after you eat. Depending on the medication, they may increase insulin release when blood sugar is elevated, reduce glucagon production, slow stomach emptying, increase feelings of fullness, and reduce appetite.
These effects help lower blood sugar and often lead to weight loss. Some GLP-1 medications are taken as weekly injections, while others are available as daily injections or oral tablets.
How Do They Compare?
- Primary action: metformin reduces liver glucose production and improves insulin sensitivity; GLP-1 medications enhance incretin hormone activity, increase satiety, and improve glucose regulation.
- Blood sugar lowering: both are effective; GLP-1 medications are often more potent, depending on the medication.
- Weight loss: metformin is usually weight neutral or produces modest weight loss; GLP-1 medications often produce greater weight loss.
- Hypoglycemia risk when used alone: very low for both.
- Route: metformin is an oral tablet; GLP-1 medications are injections or an oral tablet, depending on the medication.
- Cost: metformin is an inexpensive generic; GLP-1 medications are often substantially more expensive, though availability continues to evolve.
Both are effective medications, but they are designed to accomplish different goals.
Which Medication Lowers Blood Sugar More?
Both metformin and GLP-1 medications lower blood sugar effectively. However, many GLP-1 medications produce larger reductions in A1C than metformin alone.
That does not mean metformin is outdated or ineffective. Metformin remains an excellent starting medication because it is effective, well studied, inexpensive, and generally well tolerated. If additional blood sugar lowering is needed, a GLP-1 medication may be added rather than replacing metformin.
Which Medication Helps With Weight Loss?
This is one of the biggest differences. Metformin may lead to modest weight loss in some people, although many experience little change. GLP-1 medications generally produce greater weight loss because they increase feelings of fullness, reduce appetite, and help people eat less comfortably.
The amount of weight loss varies considerably from person to person and depends on the specific medication, dose, lifestyle habits, and other individual factors.
Which Medication Has More Side Effects?
Both medications commonly affect the digestive system, especially when treatment first begins.
Metformin
Common side effects include diarrhea, nausea, stomach discomfort, and bloating. These symptoms often improve over time or after switching to an extended-release formulation.
GLP-1 medications
Common side effects include nausea, vomiting, constipation, diarrhea, and feeling full sooner than usual. Many of these side effects also improve as the body adjusts and doses are increased gradually — see our GLP-1 nausea management guide.
Can You Take Both Together?
Yes. In fact, many people with type 2 diabetes take both metformin and a GLP-1 medication. Because they work through different mechanisms, using them together can provide additional blood sugar lowering without significantly increasing the risk of hypoglycemia when used without insulin or certain other diabetes medications. For many patients, this combination provides greater benefit than either medication alone.
Which Medication Is Better for Prediabetes?
Lifestyle changes remain the foundation of prediabetes treatment. For selected people at high risk of developing type 2 diabetes, metformin may also be recommended because it has been extensively studied for diabetes prevention.
GLP-1 medications may also reduce the risk of developing diabetes in people with overweight or obesity by improving weight and blood sugar. However, they are not currently recommended solely for prediabetes treatment in most people, and decisions about their use depend on the individual's overall medical situation and the approved indication for the medication.
Which Medication Is Better for Heart Health?
This is another important difference. Several GLP-1 medications have demonstrated cardiovascular benefits in people with type 2 diabetes who have established cardiovascular disease or are at high cardiovascular risk.
Metformin also has a long history of use and remains an important part of diabetes management, but the strongest evidence for reducing major cardiovascular events in high-risk patients comes from specific GLP-1 medications and other newer diabetes drug classes. Your healthcare provider will consider your cardiovascular risk when selecting medications.
What About Kidney Disease?
Both medication classes can play important roles in people with chronic kidney disease, but they are used differently. Metformin is generally safe for many people with mild to moderate chronic kidney disease, although dosing and continued use depend on kidney function; it may need to be reduced or discontinued if kidney function declines below recommended thresholds.
Some GLP-1 medications have demonstrated kidney-protective benefits in clinical trials, particularly by slowing the progression of diabetic kidney disease in appropriate patients. Your healthcare provider will recommend the safest treatment based on your kidney function and overall health.
Does Everyone Need a GLP-1 Medication?
No. GLP-1 medications have received significant attention because of their effectiveness for diabetes and weight management. However, they are not the right choice for everyone. Some people achieve excellent blood sugar control with healthy lifestyle habits, metformin alone, or other diabetes medications. Treatment should always be individualized rather than based on trends or advertising.
Frequently Asked Questions
Is metformin better than semaglutide?
Neither medication is universally better. Metformin is often the first medication prescribed because it is effective, inexpensive, and well studied. Semaglutide generally produces greater weight loss and larger reductions in A1C, but it may not be appropriate or necessary for every person.
Can I take metformin and a GLP-1 medication together?
Yes. Many people take both medications because they work differently and complement each other.
Will I lose more weight with a GLP-1 medication?
On average, GLP-1 medications lead to greater weight loss than metformin alone, although individual results vary.
If I start a GLP-1 medication, do I stop metformin?
Not usually. Many people continue metformin after starting a GLP-1 medication. Your healthcare provider will determine the best combination based on your blood sugar control, side effects, and treatment goals.
When Should You Contact Your Healthcare Provider?
Contact your healthcare provider if you have questions about whether metformin, a GLP-1 medication, or both are appropriate for you; experience persistent medication side effects; notice your blood sugar remains above your individualized target; develop new medical conditions that may affect your treatment plan; or are considering changing or stopping your medications.
Seek Immediate Medical Care If
Seek emergency medical attention if you experience difficulty breathing or signs of a severe allergic reaction; persistent vomiting with inability to keep fluids down; severe abdominal pain, especially if it is persistent or accompanied by vomiting; confusion, loss of consciousness, or severe hypoglycemia; or chest pain or symptoms of another medical emergency.
The Bottom Line
Metformin and GLP-1 medications are both highly effective treatments for type 2 diabetes, but they are designed to accomplish different goals. Metformin improves insulin sensitivity and reduces glucose production by the liver, while GLP-1 medications improve blood sugar regulation through incretin hormone pathways and often promote significant weight loss.
For many people, the choice is not metformin versus a GLP-1 medication—it is whether one medication alone is sufficient or whether the two should be used together. Metformin remains an excellent first-line treatment because of its long safety record, effectiveness, and affordability. GLP-1 medications have expanded treatment options by offering additional blood sugar lowering, meaningful weight loss, and cardiovascular benefits for many patients.
The best medication plan is individualized. Your healthcare provider will consider your blood sugar, weight, kidney function, cardiovascular health, treatment goals, side effects, and personal preferences to recommend the approach that offers the greatest long-term benefit.